Enhancing Equitable Access to Rare Disease Diagnosis and Treatment around the World: A Review of Evidence, Policies, and Challenges
Takeya Adachi(Keio University), Duangrurdee Wattanasirichaigoon(Mahidol University), Marshall Summar(Children's National), Camila I. Quirland Lazo(Universitat Autònoma de Barcelona), Katya A. Nogales Crespo, Ayman W. El‐Hattab(Khalifa University of Science and Technology), Ritu Jain(Nanyang Technological University), Maurizio Scarpa(Unknown)
International Journal of Environmental Research and Public Health
March 8, 2023
Cited by 157
Related Papers
Genotype-Phenotype Correlation in the Long-QT Syndrome
|Circulation|2001|1.8k
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|522
A common nonsense mutation results in α-actinin-3 deficiency in the general population
|Nature Genetics|1999|437
Mutations in the skeletal muscle α-actin gene in patients with actin myopathy and nemaline myopathy
|Nature Genetics|1999|401
Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study
|The Journal of Pediatrics|2006|364